Acute Lymphoblastic Leukemia (ALL) Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Non Hodgkin Lymphoma (NHL)
  • CD19-UCART
  • Zhengzhou, Henan, China
  • +1 more
2022-04-02
Apr 2, 2022
A
Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • (no location specified)
2022-03-28
Mar 28, 2022
A
Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Pyronaridine Tetraphosphate
  • (no location specified)
2022-03-26
Mar 26, 2022
C
Recruiting
  • Hematologic Malignancies
  • +16 more
  • A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
  • Birmingham, Alabama
  • +138 more
2022-03-17
Mar 17, 2022
S
Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +6 more
  • Anti-thymocyte globulin (rabbit)
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-01-31
Jan 31, 2022
A
Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Los Angeles, California
  • +96 more
2021-12-20
Dec 20, 2021
T
Not yet recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Bright Ideas - CIN Training
  • (no location specified)
2021-11-03
Nov 3, 2021
N
Available
  • Acute Lymphoblastic Leukemia (ALL)
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • CTL019
  • Gilbert, Arizona
  • +145 more
2021-10-28
Oct 28, 2021
S
Terminated
  • Acute Lymphoblastic Leukemia (ALL)
  • Vincristine Sulfate Liposomes Injection (VSLI)
  • Vincristine Sulfate Injection (VSI)
  • La Jolla, California
  • +14 more
2021-09-06
Sep 6, 2021
B
Active, not recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +2 more
  • CD19CAR/virus specific T cells
  • Benadryl and Tylenol
  • Houston, Texas
  • +1 more
2021-08-31
Aug 31, 2021
E
Recruiting
  • Myeloid Leukemia, Chronic
  • +8 more
  • Conventional T cells (Tcon) and Regulatory T cells (Treg)
  • Palo Alto, California
    Stanford University School of Medicine Palo Alto, California, Un
2021-08-18
Aug 18, 2021
G
Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • +4 more
  • Maywood, Illinois
  • +1 more
2021-08-01
Aug 1, 2021
S
Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • Baltimore, Maryland
  • +2 more
2021-06-08
Jun 8, 2021
S
Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • Marqibo® (vincristine sulfate liposomes injection)
  • Los Angeles, California
  • +32 more
2021-02-08
Feb 8, 2021
G
Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
2021-01-07
Jan 7, 2021
G
Completed
  • Hematological Malignancies
  • +3 more
  • Los Angeles, California
  • +14 more
2020-10-01
Oct 1, 2020
C
Active, not recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • SR-A + Epratuzumab
  • SR-B + Epratuzumab
  • Clayton, Victoria, Australia
  • +16 more
2020-08-19
Aug 19, 2020
C
Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Clayton, Victoria, Australia
  • +14 more
2020-08-14
Aug 14, 2020
M
Completed
  • Acute Myelogenous Leukemia (AML)
  • +6 more
  • ALT-803
  • Minneapolis, Minnesota
  • +2 more
2020-07-28
Jul 28, 2020
R
Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • Impact of CD9 expression level on motility assays
  • Post-transcriptional regulation of CD9
  • Rennes, France
    Rennes University Hospital
2020-08-11
Aug 11, 2020